Akathisia Occurrence Induced by Haloperidol Injection and Effectiveness of Biperiden Injection Against Delirium in Cancer Patients
10.2185/jjrm.64.808
- VernacularTitle:がん患者のせん妄における,ハロペリドール注使用によるアカシジアの発現割合とビペリデン注の有効性
- Author:
Jinwoo LEE
;
Yoriko KOBAYASHI
;
Kazuyuki NAKAMURA
;
Hiromi KURODA
- Publication Type:Journal Article
- From:Journal of the Japanese Association of Rural Medicine
2016;64(5):808-814
- CountryJapan
- Language:Japanese
-
Abstract:
When we use haloperidol (HP) parenterally to treat delirium in cancer patients, sometimes akathisia appears. So, we are pressed to give treat this symptom. The aim of this study was to investigate the occurrence rate of akathisia after HP injection and the effectiveness of biperiden injection in the treatment of akathisia. We retrospectively worked out the rate of the use of Hp injection, the rate of the occurrence of akathisia by using Hp and the effectiveness of biperiden injection in the treatment for delirium in 67 patients out of 100 patients who died in the palliative care unit (PCU) and 10 patients with delirium out of 23 patients who were under care of our palliative care team (PCT) in the sections other than the PCU from August to December of 2012. In the PCU, Hp injections were used in 52 patients (78%) out of 67 with delirium, and akathisia was suspected in 23 patients. Biperiden was injected into all of them and it was effective in 21 patients (91%). Our palliative care team gave Hp injections to seven patients (70%) out of 10 with delirium, and akathisia was suspected in one patient. At that time Hp injection was suspended but biperiden was not used. To sum up, Hp was administered to a total of 59 patients (76%) out of 77 with delirium, and akathisia was suspected in 24 patients (40%). Biperiden was used in 23 patients, all of whom were PCU patients, and effective in 21 (91%). When Hp was used to treat cancer patients with delirium, the onset of akathisia was suspected in 40% of them, but biperiden was considerably beneficial in patients with delirium.
